(Total Views: 592)
Posted On: 07/15/2024 2:43:34 PM
Post# of 148870
Re: Nt2innvovate #145142
Quote:
New data from Revolutions Bio single arm trial.
Their drug is a RAS/RAS mutant inhibitor. Leronlimab would downregulate RAS/RAS mutants via downregulation of the GTP>SRC>GRB2 pathway.
(6)
(0)Scroll down for more posts ▼
